.Pharmacolibrary.Drugs.ATC.V.V09IB04 .Pharmacolibrary.Drugs.ATC.V.V09IB04| name: | Indium111inCapromabPendetide |
| ATC code: | V09IB04 | route: | intravenous |
| n-compartments | 2 |
Indium (111In) capromab pendetide is a radiolabeled monoclonal antibody used as a diagnostic imaging agent for prostate cancer. The antibody targets prostate-specific membrane antigen (PSMA) present in prostate tissue, and the radioactive indium-111 label allows for visualization using single-photon emission computed tomography (SPECT). It was commonly used under the brand name ProstaScint, but is now largely discontinued and not commonly used in current clinical practice.
Pharmacokinetic parameters are not well-documented in published literature. Typical imaging doses were administered intravenously for adult male patients with suspected or confirmed prostate cancer.